Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ·Healthcare·Biotechnology
$4.80
+4.02%
Mkt Cap $87.64M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$22.50
Range $18.00 – $27.00
Implied Upside
+368.8%
Consensus $22.50 vs current $4.80